Share this post on:

4-Bromoflavone

4-Bromoflavone displays antioxidative and chemopreventive activities. 4-Bromoflavone activates Nrf2-Keap1-ARE complex signaling and also induces quinone reductase and other phase II enzymes. Additionally, this compound prevents the development of mammary tumors, increasing tumor latency in vivo.

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18833856

Cas No.

1218-80-0

Purity

≥98%

Formula

C15H9BrO2

Formula Wt.

301.13

IUPAC Name

6-bromo-2-phenylchromen-4-one

Synonym

6-Bromo-2-phenylbenzopyran; 6-Bromo-2-pheynyl- 4H-1-benzopyran-4-one; 6-Bromoflavone

Melting Point

176-178°C (lit.)

Appearance

Off-White crystalline powder

Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 2005 Jun 28;224(2):171-84. PMID: 15914268.

Mehta RG, Pezzuto JM. Discovery of cancer preventive agents from natural products: from plants to prevention. Curr Oncol Rep. 2002 Nov;4(6):478-86. PMID: 12354359.

Song LL, Kosmeder JW 2nd, Lee SK, et al. Cancer chemopreventive activity mediated by 4-bromoflavone, a potent inducer of phase II detoxification enzymes. Cancer Res. 1999 Feb 1;59(3):578-85. PMID: 9973203.

Motesanib